Literature DB >> 25903259

Markers of systemic exposures to products of intestinal bacteria in a dietary intervention study.

Faith I Umoh1, Ikuko Kato2, Jianwei Ren1, Phillip L Wachowiak1, Mack T Ruffin1, D Kim Turgeon3, Ananda Sen1,4, Dean E Brenner3,5, Zora Djuric6.   

Abstract

PURPOSE: Systemic exposures to intestinal bacteria may play a role in the etiology of the chronic, low-grade inflammation that is associated with western diets. Production of lipopolysaccharide-binding protein (LBP) is one biomarker of increased exposures to intestinal bacteria. This study evaluated whether changes in diet quality could affect serum LBP.
METHODS: This was a randomized, controlled trial of Mediterranean and Healthy Eating diets over 6 months in 120 healthy subjects at increased risk of colon cancer. Blood samples obtained before and after intervention were analyzed for LBP, branched-chain fatty acids characteristic of intestinal bacteria, micronutrients and cytokines. Data were analyzed for changes in LBP over time and for predictors of LBP.
RESULTS: Serum concentrations of branched-chain bacterial fatty acids declined significantly in both diet groups. However, there was no significant change in mean serum LBP concentrations with either diet intervention. In serum, LBP was positively associated with CRP and negatively associated with carotenoids both before and after intervention. After intervention, LBP was predicted positively by both CRP and bacterial fatty acid concentrations in serum, and negatively by serum carotenoids and the ω3/ω6 fatty acid ratio. This model accounted for 30 % of the inter-individual variation in serum LBP after intervention.
CONCLUSIONS: These results indicate that dietary intervention over 6 months was insufficient to alter serum LBP. The relationships with inflammation-related markers, however, indicate that anti-inflammatory strategies other than changes in diet quality, such as weight loss or improved fitness, may have more potential for reducing systemic markers of LPS exposures in well-nourished populations.

Entities:  

Keywords:  High fruit and vegetable diets; Inflammation; Intestinal bacteria; Mediterranean diet; Obesity

Mesh:

Substances:

Year:  2015        PMID: 25903259      PMCID: PMC4619169          DOI: 10.1007/s00394-015-0900-7

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  31 in total

1.  Overfeeding increases postprandial endotoxemia in men: Inflammatory outcome may depend on LPS transporters LBP and sCD14.

Authors:  Fabienne Laugerette; Maud Alligier; Jean-Philippe Bastard; Jocelyne Drai; Emilie Chanséaume; Stéphanie Lambert-Porcheron; Martine Laville; Béatrice Morio; Hubert Vidal; Marie-Caroline Michalski
Journal:  Mol Nutr Food Res       Date:  2014-03-31       Impact factor: 5.914

2.  Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease.

Authors:  Oscar Pastor Rojo; Antonio López San Román; Eduardo Albéniz Arbizu; Antonio de la Hera Martínez; Eduardo Ripoll Sevillano; Agustín Albillos Martínez
Journal:  Inflamm Bowel Dis       Date:  2007-03       Impact factor: 5.325

3.  Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance.

Authors:  J M Moreno-Navarrete; F Ortega; M Serino; E Luche; A Waget; G Pardo; J Salvador; W Ricart; G Frühbeck; R Burcelin; J M Fernández-Real
Journal:  Int J Obes (Lond)       Date:  2011-12-20       Impact factor: 5.095

Review 4.  Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia.

Authors:  Ana Paula Boroni Moreira; Tatiana Fiche Salles Texeira; Alessandra Barbosa Ferreira; Maria do Carmo Gouveia Peluzio; Rita de Cássia Gonçalves Alfenas
Journal:  Br J Nutr       Date:  2012-04-16       Impact factor: 3.718

5.  Oil composition of high-fat diet affects metabolic inflammation differently in connection with endotoxin receptors in mice.

Authors:  Fabienne Laugerette; Jean-Pierre Furet; Cyrille Debard; Patricia Daira; Emmanuelle Loizon; Alain Géloën; Christophe O Soulage; Claire Simonet; Jennifer Lefils-Lacourtablaise; Nathalie Bernoud-Hubac; Jacques Bodennec; Noël Peretti; Hubert Vidal; Marie-Caroline Michalski
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-11-15       Impact factor: 4.310

6.  Quantification of bacterial lipopolysaccharides (endotoxin) by GC-MS determination of 3-hydroxy fatty acids.

Authors:  Norbert Binding; Sabine Jaschinski; Sabine Werlich; Stefan Bletz; Ute Witting
Journal:  J Environ Monit       Date:  2003-12-02

7.  Distribution of 3-hydroxy fatty acids in tissues after intraperitoneal injection of endotoxin.

Authors:  Bogumiła Szponar; Leonard Kraśnik; Tomasz Hryniewiecki; Andrzej Gamian; Lennart Larsson
Journal:  Clin Chem       Date:  2003-07       Impact factor: 8.327

8.  Selective use of L-valine and L-isoleucine for the biosynthesis of branched-chain fatty acids in rat skin.

Authors:  H Oku; M Onotogi; J Nagata; K Wada; I Chinen
Journal:  Biosci Biotechnol Biochem       Date:  1995-05       Impact factor: 2.043

9.  A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction.

Authors:  José María Moreno-Navarrete; Xavier Escoté; Francisco Ortega; Matteo Serino; Mark Campbell; Marie-Caroline Michalski; Martine Laville; Gemma Xifra; Elodie Luche; Pere Domingo; Mónica Sabater; Gerard Pardo; Aurelie Waget; Javier Salvador; Marta Giralt; Jose I Rodriguez-Hermosa; Marta Camps; Catherine I Kolditz; Nathalie Viguerie; Jean Galitzky; Pauline Decaunes; Wifredo Ricart; Gema Frühbeck; Francesc Villarroya; Geltrude Mingrone; Dominique Langin; Antonio Zorzano; Hubert Vidal; Joan Vendrell; Remy Burcelin; Antonio Vidal-Puig; José Manuel Fernández-Real
Journal:  Diabetologia       Date:  2013-08-21       Impact factor: 10.122

10.  Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity.

Authors:  Arturo Gonzalez-Quintela; Manuela Alonso; Joaquin Campos; Luis Vizcaino; Lourdes Loidi; Francisco Gude
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

View more
  15 in total

1.  A Mediterranean diet does not alter plasma trimethylamine N-oxide concentrations in healthy adults at risk for colon cancer.

Authors:  Laura E Griffin; Zora Djuric; Chris J Angiletta; Cassie M Mitchell; Mary E Baugh; Kevin P Davy; Andrew P Neilson
Journal:  Food Funct       Date:  2019-04-02       Impact factor: 5.396

2.  Gut Microbiota and Cardiometabolic Risk Factors in Hemodialysis Patients: A Pilot Study.

Authors:  Annabel Biruete; Jacob M Allen; Brandon M Kistler; Jin Hee Jeong; Peter J Fitschen; Kelly S Swanson; Kenneth R Wilund
Journal:  Top Clin Nutr       Date:  2019 Apr-Jun       Impact factor: 0.508

3.  Colonic Mucosal Bacteria Are Associated with Inter-Individual Variability in Serum Carotenoid Concentrations.

Authors:  Zora Djuric; Christine M Bassis; Melissa A Plegue; Jianwei Ren; Rena Chan; ElKhansa Sidahmed; D Kim Turgeon; Mack T Ruffin; Ikuko Kato; Ananda Sen
Journal:  J Acad Nutr Diet       Date:  2017-12-21       Impact factor: 4.910

4.  Increases in Colonic Bacterial Diversity after ω-3 Fatty Acid Supplementation Predict Decreased Colonic Prostaglandin E2 Concentrations in Healthy Adults.

Authors:  Zora Djuric; Christine M Bassis; Melissa A Plegue; Ananda Sen; D Kim Turgeon; Kirk Herman; Vincent B Young; Dean E Brenner; Mack T Ruffin
Journal:  J Nutr       Date:  2019-07-01       Impact factor: 4.798

Review 5.  Obesity-associated cancer risk: the role of intestinal microbiota in the etiology of the host proinflammatory state.

Authors:  Zora Djuric
Journal:  Transl Res       Date:  2016-07-28       Impact factor: 7.012

6.  Genetically determined elevated C-reactive protein associated with primary colorectal cancer risk: Mendelian randomization with lifestyle interactions.

Authors:  Su Yon Jung; Herbert Yu; Matteo Pellegrini; Jeanette C Papp; Eric M Sobel; Zuo-Feng Zhang
Journal:  Am J Cancer Res       Date:  2021-04-15       Impact factor: 6.166

7.  High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments.

Authors:  Hsiao-Ching Nien; Shih-Jer Hsu; Tung-Hung Su; Po-Jen Yang; Jin-Chuan Sheu; Jin-Town Wang; Lu-Ping Chow; Chi-Ling Chen; Jia-Horng Kao; Wei-Shiung Yang
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

8.  Dietary patterns reflecting healthy food choices are associated with lower serum LPS activity.

Authors:  Aila J Ahola; Mariann I Lassenius; Carol Forsblom; Valma Harjutsalo; Markku Lehto; Per-Henrik Groop
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

9.  Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases: protocol for a prospective cohort study of prognostic factors and personalised medicine.

Authors:  Robin Christensen; Berit L Heitmann; Karina Winther Andersen; Ole Haagen Nielsen; Signe Bek Sørensen; Mohamad Jawhara; Anette Bygum; Lone Hvid; Jakob Grauslund; Jimmi Wied; Henning Glerup; Ulrich Fredberg; Jan Alexander Villadsen; Søren Geill Kjær; Jan Fallingborg; Seyed A G R Moghadd; Torben Knudsen; Jacob Brodersen; Jesper Frøjk; Jens Frederik Dahlerup; Anders Bo Bojesen; Grith Lykke Sorensen; Steffen Thiel; Nils J Færgeman; Ivan Brandslund; Tue Bjerg Bennike; Allan Stensballe; Erik Berg Schmidt; Andre Franke; David Ellinghaus; Philip Rosenstiel; Jeroen Raes; Mette Boye; Lars Werner; Charlotte Lindgaard Nielsen; Heidi Lausten Munk; Anders Bathum Nexøe; Torkell Ellingsen; Uffe Holmskov; Jens Kjeldsen; Vibeke Andersen
Journal:  BMJ Open       Date:  2018-02-08       Impact factor: 2.692

Review 10.  Dysbiosis in the Development of Type I Diabetes and Associated Complications: From Mechanisms to Targeted Gut Microbes Manipulation Therapies.

Authors:  Gratiela Gradisteanu Pircalabioru; Nicolae Corcionivoschi; Ozan Gundogdu; Mariana-Carmen Chifiriuc; Luminita Gabriela Marutescu; Bogdan Ispas; Octavian Savu
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.